文献速递瓣膜外科先天性心脏病外科

儿童罗斯手术治疗的先天性心脏病全景分析

The landscape of congenital heart disease treated with the Ross procedure.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-09-12

该研究回顾30年间317例接受罗斯手术的儿童患者,按年龄和解剖分为4组和3组。结果显示,新生儿和婴儿的手术死亡率和并发症较高,而孤立性主动脉瓣病变患者无论年龄预后均最佳;复杂先心病与较低的生存率和较高的LVOT再干预风险相关。

要点

  • 新生儿和婴儿的Shone综合征、复杂先心病、同期根部扩大和弓部手术比例最高(P<.001)。
  • 总体手术死亡率为4.4%(14/317),并发症为14%(44/317),新生儿和婴儿更高(P<.001)。
  • 孤立性主动脉瓣病变患者10年生存率和免于LVOT再干预率显著优于复杂先心病患者(P<.001和P=.005)。

核心结论

  • 在儿童患者中,无论年龄,孤立性主动脉瓣病变患者最适合罗斯手术;复杂先心病与较低的生存率和增加的LVOT再干预风险相关。

研究设计与样本

  • 回顾性分析30年间317例接受罗斯手术的儿童患者,按年龄分为新生儿(<31天,n=21)、婴儿(31天-1岁,n=40)、儿童(1-12岁,n=165)和青少年(13-18岁,n=91),按解剖分为孤立性主动脉瓣病变(n=221)、Shone综合征或多水平左室流出道梗阻(n=61)和复杂先心病(n=35),比较各组结局。

主要发现

  • 新生儿和婴儿的Shone综合征(P<.001)、复杂先心病(P<.001)、同期根部扩大(P<.001)和弓部手术(P<.001)比例最高。
  • 总体手术死亡率为4.4%(n=14/317),并发症为14%(n=44/317),两者在新生儿和婴儿中更高(P均<.001),在孤立性主动脉瓣病变患者中更低(P均<.001)。
  • 总体10年生存率和免于LVOT再干预率分别为92%和81%,孤立性主动脉瓣病变患者显著优于复杂先心病患者(P<.001和P=.005)。
  • 在新生儿和婴儿孤立性主动脉瓣病变患者中,手术死亡率为4%(n=1/23),并发症为9%(n=2/23),10年生存率为85.6%,10年免于LVOT再干预率为88.4%。

临床怎么用

  • 对于儿童孤立性主动脉瓣病变患者,罗斯手术可作为首选术式,不受年龄限制。
  • 对于复杂先心病患者,需权衡罗斯手术的较低生存率和较高的LVOT再干预风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Ross procedure has excellent outcomes in the pediatric population. Some series have reported age- and anatomy-dependent outcomes, but a comprehensive analysis stratified by these variables has not been reported to date. We sought to describe the landscape of congenital heart disease (CHD) treated with the Ross procedure and identify the patients best served by this operation. METHODS: Over a total of 30 years, 317 pediatric patients underwent the Ross procedure. These patients were stratified into 4 age groups-neonates (age <31 days; n = 21), infants (age 31 days to 1 year; n = 40), children (age 1-12 years; n = 165), and adolescents (age 13-18 years; n = 91)-and 3 anatomic groups-isolated aortic valve (AV) disease (n = 221), Shone complex or multilevel left ventricular outflow tract (LVOT) obstruction (n = 61), and complex CHD (n = 35). The groups were compared across outcomes. RESULTS: Neonates and infants had the highest rates of Shone syndrome (P < .001), complex CHD (P < .001), concomitant root enlargement (P < .001), and arch procedures (P < .001). Operative mortality and morbidity were 4.4% (n = 14/317) and 14% (n = 44/317), respectively. Both were higher in neonates and infants (P < .001 for both) but lower for patients with isolated AV disease (P < .001 for both). Ten-year survival and freedom from LVOT reintervention were 92% and 81%, respectively, and were significantly better in patients with isolated AV disease compared to those with complex CHD (P < .001 and P = .005, respectively). In neonates and infants with isolated AV disease, operative mortality was 4% (n = 1/23), morbidity was 9% (n = 2/23), 10-year survival was 85.6%, and 10-year freedom from LVOT reintervention was 88.4%. CONCLUSIONS: Among pediatric patients, those with isolated AV disease are best served with the Ross procedure, regardless of age. Complex CHD is associated with lower survival and increased risk of LVOT reintervention.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bojko MM, Wiggins L, Cleveland JD, et al. The landscape of congenital heart disease treated with the Ross procedure. J Thorac Cardiovasc Surg. 2024. PMID: 39260598. doi:10.1016/j.jtcvs.2024.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。